En Es
Categories

Industry News

Global POC Infectious Disease Market to Reach USD 1.9 Billion by 2025

By Labmedica International staff writers
09 Jan 2018

Image: The global point-of-care infectious disease diagnostics/testing market is expected to reach USD 1.90 billion by 2025 (Photo courtesy of iStock).The global point-of-care (POC) infectious disease diagnostics/testing market is expected to reach USD 1.90 billion by 2025, as the emerging trend of patient-centric services and increase in complicated infectious disorders drives an upsurge in the demand for portable and accurate detection devices.

These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.

Portable devices with the potential to enable rapid detection of infectious diseases are revolutionizing patient care and driving the growing demand for decentralized testing settings. Additionally, increased R&D investments for the development of new products are expected to further drive the POC infectious disease diagnostics/testing market. For instance, an EU project research team has developed a new lab-on-a-disc' technology that aids in the diagnosis of various infectious diseases, including malaria. Through POC treatment, the technology enables faster diagnosis and allows precise administration of drugs, thereby driving its adoption.

HIV POC is estimated to account for the largest share of the POC infectious disease diagnostics/testing market due to the rising incidence rate of the disease. Companies are also adopting a quality management approach towards the introduction of novel tests for HIV diagnosis. TB and drug resistant TB are anticipated to witness lucrative demand over the coming years on account of their rising incidence rate, fueled further by the implementation of fully or partially integrated nano/microscale technologies for developing drug resistant TB diagnostic devices.

The demand for the development of inexpensive, rapid, simple, and accurate tests capable of simultaneously detecting multiple biomarkers is expected to contribute to the market growth. Moreover, advances in bio sensing technology for early detection with sensitivity are expected to drive revenue for the market players over the coming years.

Geographically, North America dominates the global market for POC infectious disease diagnostics/testing, due to adequate administration support, well-established healthcare framework, and extensive R&D upgradation in the region. However, the Asia Pacific market is expected to record the fastest growth over the forecast period due to the rising incidence and prevalence rates of infectious diseases in the region as well as favorable government support.

Related Links:
Research and Markets



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

15 Oct 2018
AI Algorithm Uses Key Signatures to Predict Onset of AD
A team of researchers has designed an artificial intelligence (AI) algorithm that learns signatures from magnetic resonance imaging (MRI), genetics, and clinical data to accurately predict cognitive decline leading to Alzheimer’s disease. The algorithm can help predict whether an individual’s cognitive faculties are likely to deteriorate towards Alzheimer’s in the next five years.
Read More
15 Oct 2018
Breast Cancer Screening Machine Learning Software Receives CE Mark
A new deep learning-based breast cancer screening software has received the CE mark and will be launched within the UK’s National Health Service (NHS) and European healthcare systems. The software has been developed by Kheiron Medical Technologies, a start-up that combines novel deep learning methods, data science, and radiology expertise to enable diagnostics designed to detect cancers and improve patient outcomes.
Read More
15 Oct 2018
GE Healthcare to Implement First AI-Powered Hospital Command Centers
GE Healthcare is collaborating with hospital service providers in Europe and the US for implementing an artificial intelligence (AI)-powered command center to effectively and efficiently synchronize all elements of a patient's hospital experience. The AI-powered system will support caregivers to enhance patient safety, orchestrate seamless care delivery and get patients back home sooner.
Read More
11 Oct 2018
Scientists Use Machine Learning and MRI Scans to Predict Learning Difficulties
A team of scientists from the Medical Research Council (MRC) Cognition and Brain Sciences Unit at the University of Cambridge used machine learning - a type of artificial intelligence - with data from hundreds of children who struggle at school to identify clusters of learning difficulties, which did not match their previous diagnosis. According to the researchers, this reinforces the need for children to receive detailed assessments of their cognitive skills to identify the best type of support.
Read More
10 Oct 2018
Utilization of X-Ray Mammography Systems Expected to Increase
Over the last 20 years, hospitals and imaging centers in the developed economies have adopted X-ray mammography systems for the screening and diagnosis of breast cancer. This has resulted in a significant reduction in mortality and encouraged emerging countries to make investments in population-base, organized screening. These significant investments in mammography technology have paved the way for radiation safety, patient comfort and 3D imaging that enables precise tumor detection.
Read More
09 Oct 2018
Compact Devices Emerge As Segment of Ultrasound Market
The global ultrasound devices market was valued at USD 6.5 billion in 2017 and is projected to grow at a CAGR of 5.6% from 2018 to 2026 to reach USD 10.6 billion by 2026, as a surge in the incidence of disorders such as cardiovascular diseases, respiratory and abdominal disorders is likely to boost the demand for ultrasound devices.
Read More
02 Oct 2018
AI and fMRI Show How Brain Connects Memories to Solve Problems
A team of German neuroscientists and Artificial Intelligence (AI) researchers have published results from their study that provided insights into the way the human brain connects individual episodic memories, or memories of specific events, to solve problems.
Read More
02 Oct 2018
Medical Robots Market to Reach USD 28 Billion in 2025
The global medical robots market is estimated to grow with a CAGR of 22.3% from USD 5.74 billion in 2017 to USD 28.78 billion in 2025, driven by increasing training programs for robotic surgeries and a rise in the usage of robots across various healthcare fields such as surgeries, therapies, rehabilitation, pharmacy dispensing, sanitation and others. These are the latest findings of Research and Markets, a global market research company.
Read More
01 Oct 2018
AI Tool Identifies Cancer Type and Changes in Lung Tumor
Researchers from the NYU School of Medicine have developed a new computer program that can analyze the images of patients' lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth. In their study, the researchers found that the artificial intelligence (AI), or "machine learning," program could distinguish -- with 97% accuracy -- between adenocarcinoma and squamous cell carcinoma, two lung cancer types that experienced pathologists at times struggle to parse without confirmatory tests. Additionally, the study found that the AI was also able to determine from analyzing the images whether the abnormal versions of six genes linked to lung cancer – including EGFR, KRAS and TP53 – were present in cells, with an accuracy ranging from 73% to 86%, depending upon the gene.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions